DK1025245T3 - Hurtig etablering af stabile pattedyrscelelinjer, der producerer höje koncentrationer af rekombinante proteiner - Google Patents
Hurtig etablering af stabile pattedyrscelelinjer, der producerer höje koncentrationer af rekombinante proteinerInfo
- Publication number
- DK1025245T3 DK1025245T3 DK98953816T DK98953816T DK1025245T3 DK 1025245 T3 DK1025245 T3 DK 1025245T3 DK 98953816 T DK98953816 T DK 98953816T DK 98953816 T DK98953816 T DK 98953816T DK 1025245 T3 DK1025245 T3 DK 1025245T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell lines
- recombinant proteins
- mammalian cell
- high concentrations
- producing high
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
- C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6344997P | 1997-10-29 | 1997-10-29 | |
US09/175,690 US6136536A (en) | 1997-10-29 | 1998-10-20 | Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1025245T3 true DK1025245T3 (da) | 2006-08-21 |
Family
ID=26743435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98953816T DK1025245T3 (da) | 1997-10-29 | 1998-10-21 | Hurtig etablering af stabile pattedyrscelelinjer, der producerer höje koncentrationer af rekombinante proteiner |
Country Status (12)
Country | Link |
---|---|
US (1) | US6136536A (da) |
EP (1) | EP1025245B1 (da) |
JP (2) | JP2001520882A (da) |
AT (1) | ATE326537T1 (da) |
AU (1) | AU740768B2 (da) |
CA (1) | CA2306449C (da) |
CY (1) | CY1105290T1 (da) |
DE (1) | DE69834565T2 (da) |
DK (1) | DK1025245T3 (da) |
ES (1) | ES2263225T3 (da) |
PT (1) | PT1025245E (da) |
WO (1) | WO1999021976A2 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083378A2 (en) * | 2003-03-17 | 2004-09-30 | Emory University | Mammalian cell lines specifically deficient in o-linked glycosylation |
KR100533794B1 (ko) * | 2003-10-02 | 2005-12-07 | 주식회사 프로젠 | 인간 난포자극 호르몬을 대량으로 생산하는 방법 |
EP1687017B1 (en) | 2003-10-24 | 2013-03-06 | Gencia Corporation | Methods and compositions for delivering polynucleotides |
US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
ATE550041T1 (de) | 2004-01-21 | 2012-04-15 | Novo Nordisk Healthcare Ag | Transglutaminase-vermittelte konjugation von peptiden |
EP2147105B1 (en) | 2007-05-02 | 2013-04-24 | Merial Limited | Dna plasmids having improved expression and stability |
US20090123494A1 (en) * | 2007-07-31 | 2009-05-14 | William Staplin | Momlv-based pseudovirion packaging cell line |
BRPI0917000A2 (pt) * | 2008-08-06 | 2016-02-16 | Novo Nordisk Healthcare Ag | proteínas conjugadas com eficácia in vivo prolongada |
EP2389389B1 (en) | 2009-01-22 | 2015-04-15 | Novo Nordisk Health Care AG | Stable growth hormone compounds |
US8841249B2 (en) | 2009-08-06 | 2014-09-23 | Novo Nordisk A/S | Growth hormones with prolonged in-vivo efficacy |
CA2787895A1 (en) | 2010-01-22 | 2011-07-28 | Novo Nordisk Health Care Ag | Stable growth hormone compounds |
MX345736B (es) | 2010-01-22 | 2017-02-14 | Novo Nordisk Healthcare Ag | Hormonas de crecimiento con eficacia in vivo prolongada. |
WO2012010516A1 (en) | 2010-07-22 | 2012-01-26 | Novo Nordisk Health Care Ag | Growth hormone conjugates |
JP6464145B2 (ja) | 2013-04-05 | 2019-02-06 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 成長ホルモン化合物製剤 |
DK3218514T3 (da) | 2014-11-12 | 2019-10-21 | Lek Pharmaceuticals | Forudsigelse af genetisk stabil rekombinant proteinproduktion i tidlig cellelinieudvikling |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740461A (en) * | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
US5550036A (en) * | 1986-04-09 | 1996-08-27 | Eli Lilly And Company | Method for co-amplification of human protein C genes in human cells |
US5094953A (en) * | 1988-03-21 | 1992-03-10 | Genentech, Inc. | Human tissue plasminogen activator variants |
AU6125294A (en) * | 1993-01-13 | 1994-08-15 | Genetics Institute Inc. | Process for producing m-csf 223 |
DE69420033T2 (de) * | 1993-04-06 | 1999-12-23 | Us Gov Health & Human Serv | Gibbon leukemia virus retrovirale vektoren |
EP0705334A1 (en) * | 1993-06-14 | 1996-04-10 | Basf Aktiengesellschaft | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
US5866755A (en) * | 1993-06-14 | 1999-02-02 | Basf Aktiengellschaft | Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
US6004941A (en) * | 1993-06-14 | 1999-12-21 | Basf Aktiengesellschaft | Methods for regulating gene expression |
US5464758A (en) * | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
JPH08305625A (ja) * | 1995-05-11 | 1996-11-22 | Hitachi Ltd | 演算処理機能付き半導体メモリ及びそれを用いた処理装置 |
US5891718A (en) * | 1996-03-27 | 1999-04-06 | Vical Incorporated | Tetracycline inducible/repressible systems |
-
1998
- 1998-10-20 US US09/175,690 patent/US6136536A/en not_active Expired - Lifetime
- 1998-10-21 EP EP98953816A patent/EP1025245B1/en not_active Expired - Lifetime
- 1998-10-21 DK DK98953816T patent/DK1025245T3/da active
- 1998-10-21 JP JP2000518068A patent/JP2001520882A/ja not_active Withdrawn
- 1998-10-21 AU AU11091/99A patent/AU740768B2/en not_active Ceased
- 1998-10-21 WO PCT/US1998/022231 patent/WO1999021976A2/en active IP Right Grant
- 1998-10-21 CA CA002306449A patent/CA2306449C/en not_active Expired - Lifetime
- 1998-10-21 DE DE69834565T patent/DE69834565T2/de not_active Expired - Lifetime
- 1998-10-21 PT PT98953816T patent/PT1025245E/pt unknown
- 1998-10-21 ES ES98953816T patent/ES2263225T3/es not_active Expired - Lifetime
- 1998-10-21 AT AT98953816T patent/ATE326537T1/de not_active IP Right Cessation
-
2006
- 2006-07-31 CY CY20061101077T patent/CY1105290T1/el unknown
-
2009
- 2009-08-21 JP JP2009191858A patent/JP2010000087A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2306449C (en) | 2008-12-16 |
AU1109199A (en) | 1999-05-17 |
JP2010000087A (ja) | 2010-01-07 |
WO1999021976A2 (en) | 1999-05-06 |
ES2263225T3 (es) | 2006-12-01 |
CY1105290T1 (el) | 2010-03-03 |
AU740768B2 (en) | 2001-11-15 |
ATE326537T1 (de) | 2006-06-15 |
EP1025245B1 (en) | 2006-05-17 |
DE69834565D1 (de) | 2006-06-22 |
CA2306449A1 (en) | 1999-05-06 |
WO1999021976A3 (en) | 1999-07-08 |
US6136536A (en) | 2000-10-24 |
DE69834565T2 (de) | 2007-04-26 |
JP2001520882A (ja) | 2001-11-06 |
EP1025245A2 (en) | 2000-08-09 |
PT1025245E (pt) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1025245T3 (da) | Hurtig etablering af stabile pattedyrscelelinjer, der producerer höje koncentrationer af rekombinante proteiner | |
DK1088084T3 (da) | Erythropoietin analog-humant serumalbumin fusionsprotein | |
ATE500323T1 (de) | Subtilisin-variante | |
ATE295416T1 (de) | Humanisiertes grünes-fluoreszenzprotein und methoden | |
DE69836092D1 (de) | Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen | |
DE69839215D1 (de) | Dendritische zellhybride | |
DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
EA200000007A1 (ru) | Регуляция экспрессии хинолятфосфорибозил-трансферазы | |
ATE263841T1 (de) | Praktische in vitro sialylierung von rekombinanten glykpproteinen | |
DK1137808T3 (da) | Fremgangsmåde til fremstilling af rekombinante celler | |
IS5959A (is) | Aðferð til hástigstjáningar virkra lífvessaeiturefnis-ß-þegaónæmisglóbúlínshermiprótína og hreinsunar þeirra | |
DK1131444T3 (da) | Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse | |
DE59903410D1 (de) | Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung | |
DE60226852D1 (de) | Lentivirale verpackungskonstrukte | |
DE69630955T2 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
DE69841015D1 (de) | Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2 | |
DK1117798T3 (da) | Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider | |
DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
ES2152313T3 (es) | Gen grb-3-3, sus variantes y sus utilizaciones. | |
ATE309370T1 (de) | Retinoid-metabolisierendes protein | |
ES2172801T3 (es) | Procedimiento y dispositivo para la purificacion y enriquecimiento de moleculas. | |
DK0658626T3 (da) | Fremgangsmåder til produktion af protein C | |
DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
DE69737597D1 (de) | Vektoren zur inhibierung von viralem und tumorwachstum | |
DE69733948D1 (de) | In vivo herstellung von replicativen molekülen |